GeekWire

SEPTEMBER 10, 2021

CaaMTech , a Seattle-area startup developing new psychedelic agents, has raised $22 million in funding, the company announced this week. CaaMTech is developing a suite of tryptamines with the aim of finding mixes that “optimize desired effects while minimizing unwanted side-effects,” according to the company’s website.

Chemicals 145

Chemicals Pharmaceuticals Research Study 145

The Verge

OCTOBER 7, 2021

This is a major shift for the country that is the European headquarters for many large US pharmaceutical companies, as well as tech firms, including Google, Apple, and Facebook. Companies typically create Irish subsidiaries of their companies that license their intellectual property, on which the subsidiary pays royalties.

Google 128

Google Apple Pharmaceuticals Licensing 128

GeekWire

JANUARY 14, 2021

AltPep is developing tools and treatments for diseases caused by amyloid proteins that are incorrectly folded and create harmful deposits. The UW has licensed the exclusive rights of this intellectual property to the startup. Another Seattle-area biotech startup, Athira Pharma, is also developing treatments for Alzheimer’s.

Real Estate 145

Real Estate Biotechnology Pharmaceuticals Licensing 145

GeekWire

SEPTEMBER 15, 2021

The funding will fuel Alpine’s program developing ALPN-303, designed to treat lupus and other inflammatory diseases. That payment is part of a licensing deal inked last year with the pharmaceutical giant for clinical testing of another immune-modulating agent, ALPN-101, for lupus.

Healthcare 110

Healthcare Study Pharmaceuticals Programming 110

GeekWire

MAY 6, 2021

Double strands of innovation: TwinStrand, which spun out of the University of Washington, has developed technology in both gene sequencing and analyzing sequencing results to help it find what the company calls “genetic needles in the haystack.” Total venture capital funding is now north of $70 million for the 6-year-old company.

Pharmaceuticals 120

Pharmaceuticals Chemicals Small Business Healthcare 120

GeekWire

MARCH 4, 2024

GeekWire Photo / Charlotte Schubert) The Institute for Protein Design at the University of Washington is a startup factory , spinning out companies developing new protein-based therapeutics, industrial enzymes, materials, biosensors and more. billion acquisition of IPD spinout Icosavax, which develops vaccines.

Tools 112

Tools Study Energy Development 112

GeekWire

SEPTEMBER 14, 2020

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. billion if development milestones are met, and another $1.75

Biotechnology 73

Biotechnology Pharmaceuticals Journal Licensing 73

CIO Business Intelligence

AUGUST 11, 2023

Eli Lilly overcomes translation bottleneck: With global teams working in a variety of languages, the pharmaceutical firm developed Lilly Translate, a home-grown NLP solution, to help translate everything from internal training materials and formal, technical communications to regulatory agencies. NLTK is offered under the Apache 2.0

Course 142

Course Open Source Artificial Intelligence Training 142

GeekWire

SEPTEMBER 3, 2021

“When I founded the company, I never really expected to get a product on the market to patients,” said Hoekman, who served as CEO until 2017 and is now chief technology and development officer. It’s been a “big challenge to shift from a device technology-focused company to what is now a pretty integrated pharmaceutical company,” said Hoekman.

Pharmaceuticals 99

Pharmaceuticals Study Company System 99

GeekWire

MARCH 18, 2022

The investment firm’s team includes senior associate Dasom (Christine) Yoo , former Fred Hutchinson Cancer Research Center business development manager. However, the company said the papers containing altered images were not cited in its patent filing for its lead development candidate, ATH-1017. GeekWire Photo / Kevin Lisota).

Company 89

Company Biotechnology Research Journal 89

The Verge

MARCH 17, 2022

It took less than six hours for drug-developing AI to invent 40,000 potentially lethal molecules. The AI came up with tens of thousands of new substances, some of which are similar to VX, the most potent nerve agent ever developed. He’s also a senior scientist at Collaborations Pharmaceuticals, Inc.,

Chemicals 145

Chemicals Open Source Research Conference 145

CIO Business Intelligence

JULY 5, 2022

Developed by Zuellig Pharma, eZRx is ASEAN’s largest B2B eCommerce platform for the healthcare industry – offering a smarter and more convenient way to buy and sell healthcare products online, anywhere and anytime, versus reps visiting clients face-to-face. And it happened to launch when the world needed it most.

Healthcare 98

Healthcare Groups Development SAP 98

Trends in the Living Networks

JANUARY 30, 2007

Open innovation , the most talked-about development in corporate innovation, is fundamentally based on tapping external networks. Examples included Cisco’s extended network, value flows in the pharmaceutical industry and an engineering firm, among others. Free chapters) Implementing Enterprise 2.0

Network 90

Network Trends Media Social 90

Trends in the Living Networks

MAY 22, 2006

Each of these companies has developed fairly mature offerings, and gained traction in the corporate marketplace, with a number of leading audit firms, investment banks, and pharmaceutical companies in the process of implementing their software. See some screenshots here. Free chapters) Implementing Enterprise 2.0

Network 60

Network Social Trends Enterprise 60

Trends in the Living Networks

APRIL 10, 2008

Executive Forum , one of the showcased companies, Janssen-Cilag, an Australian pharmaceutical subsidiary of Johnson & Johnson, gave us a snapshot of an internal tool they’ve developed called Jitter (see Nathan Wallace’s presentation and resources on his blog ), which is essentially Twitter for the enterprise.

Network 60

Network Social Trends Enterprise 60

CIO Business Intelligence

MAY 4, 2022

The company plans to apply those technologies in the development of software-as-a-service products for the enterprise, tackling problems such as cybersecurity, navigation, and drug discovery. Or of formulas and know-how and trade secrets at pharmaceutical and biotech companies. Hidary, an energetic figure, is a serial entrepreneur.

Enterprise 96

Enterprise Enterprise Banking Software 96

Vox

DECEMBER 11, 2022

Neuralink, a startup co-founded by Musk in 2016, aims to develop a brain chip implant that it claims could one day help paralyzed people walk and blind people see. The same goes for inventing important new medical devices, pharmaceutical drugs, and vaccines. It’s what Winders calls “animal experimentation exceptionalism.”.

Research 99

Research Study Report Social 99

GeekWire

JANUARY 2, 2021

But even more important is to think about the technologies you are developing for the next long phase, which is about Resilience for the future. And I’ll earn my A-class license on iRacing…. The tech industry has contributed to polarization through the various social media platforms that we developed. The tech backlash is real.

Industry 145

Industry Sports Social CTO Hire 145

The Verge

AUGUST 31, 2021

So you buy a processing unit design from somebody like Arm in the UK, who is very popular, and then maybe you need the USB interface, so you get a USB IP block, which you license. So you decide, “I want to build a controller chip.” And by the way, DARPA had funded pandemic preparedness research at Moderna half a decade ago.

Intel 134

Intel Company Industry Tools 134

Trends in the Living Networks

FEBRUARY 6, 2008

Intimate relationships now can be developed online via email, text messaging and phone sex, and they can be ended this way, too. Printing gave rise to the production of "penny dreadfuls," while one of the early developments of still photography was the "what the butler saw" machine. At the time this article was written, a U.S.

Trends 108

Trends Network Media Social 108

GeekWire

JANUARY 17, 2022

to come out firmly for the TRIPS [intellectual property] waivers so that we could license these vaccines around the globe, wherever there was capacity, and make sure that we could produce them in other countries. . “The U.S. and all of the other wealthier countries have to put a lot more money in.” That is really critical.

Healthcare 113

Healthcare Government Social System 113

Vox

AUGUST 1, 2023

Indeed, the US government’s record to date on AI has mostly involved vague calls for “continued United States leadership in artificial intelligence research and development” or “adoption of artificial intelligence technologies in the Federal Government,” which is fine, but not exactly concrete policy. Principles, rather than programming.

Artificial Intelligence 69

Artificial Intelligence Training Government Research 69